US20020183288A1
(en)
*
|
1995-04-03 |
2002-12-05 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
US6413536B1
(en)
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
EP0959873B1
(de)
*
|
1996-12-20 |
2006-03-01 |
ALZA Corporation |
Gelzusammensetzungen und verfahren
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
US6994851B1
(en)
|
1997-07-10 |
2006-02-07 |
Mannkind Corporation |
Method of inducing a CTL response
|
US6193991B1
(en)
|
1997-10-29 |
2001-02-27 |
Atul J. Shukla |
Biodegradable delivery systems of biologically active substances
|
US6733767B2
(en)
*
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
US7128927B1
(en)
*
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
US7919109B2
(en)
*
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
CN1232244C
(zh)
*
|
1999-02-08 |
2005-12-21 |
阿尔萨公司 |
稳定的非水性单相粘性载体及采用该载体的制剂
|
IT1308187B1
(it)
*
|
1999-02-16 |
2001-12-07 |
Formenti Farmaceutici Spa |
Composizioni farmaceutiche topiche a base di antiinfiammatori nonsteroidei.
|
US7018365B2
(en)
|
1999-05-21 |
2006-03-28 |
Micro Therapeutics, Inc. |
Threaded syringe with quick stop
|
EP1949890A3
(de)
|
1999-06-04 |
2011-05-18 |
ALZA Corporation |
Implantierbare Gelzusammensetzungen und Herstellungsverfahren dafür
|
CA2372994C
(en)
*
|
1999-06-04 |
2010-03-23 |
Alza Corporation |
Implantable gel compositions and method of manufacture
|
AU6058000A
(en)
*
|
1999-07-12 |
2001-01-30 |
Scimed Life Systems, Inc. |
Liquid based vaso-occlusive compositions
|
US6461631B1
(en)
*
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
FR2802923B1
(fr)
*
|
1999-12-28 |
2002-03-08 |
Roquette Freres |
Procede de preparation d'une composition d'ester d'acide lactique et son utilisation en tant que solvant
|
US6465425B1
(en)
*
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
US20030211974A1
(en)
*
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
US6998137B2
(en)
*
|
2000-04-07 |
2006-02-14 |
Macromed, Inc. |
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
|
KR100722896B1
(ko)
*
|
2000-04-12 |
2007-05-30 |
산꼬 가가꾸 고교 가부시끼가이샤 |
제전성 조성물
|
DK1274459T3
(da)
|
2000-04-19 |
2006-02-06 |
Genentech Inc |
Præparater med vedholdende frigivelse indeholdende væksthormon
|
SG98393A1
(en)
|
2000-05-19 |
2003-09-19 |
Inst Materials Research & Eng |
Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
|
WO2002000137A1
(en)
*
|
2000-06-28 |
2002-01-03 |
Shukla Atul J |
Biodegradable vehicles and delivery systems of biologically active substances
|
US20060177416A1
(en)
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
US7666445B2
(en)
*
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
US20020106406A1
(en)
*
|
2000-12-08 |
2002-08-08 |
Mchugh Anthony J. |
Crystallizable/non-crystallizable polymer composites
|
US7088002B2
(en)
*
|
2000-12-18 |
2006-08-08 |
Intel Corporation |
Interconnect
|
ATE375145T1
(de)
|
2000-12-21 |
2007-10-15 |
Alrise Biosystems Gmbh |
Induziertes phasenübergangs verfahren zur herstellung von hydrophile wirkstoffe enthaltende mikropartikeln
|
US20020114795A1
(en)
|
2000-12-22 |
2002-08-22 |
Thorne Kevin J. |
Composition and process for bone growth and repair
|
US6500408B2
(en)
|
2001-01-27 |
2002-12-31 |
Jc Technologies, Inc. |
Enamel-safe tooth bleach and method for use
|
DK1372729T3
(da)
*
|
2001-02-23 |
2009-06-22 |
Genentech Inc |
Nedbrydelige polymere til injektion
|
DE60227069D1
(de)
*
|
2001-02-27 |
2008-07-24 |
Univ Rochester |
VERFAHREN UND ZUSAMMENSETZUNGEN ZUR MODIFIKATION DER BEARBEITUNG VON APOLIPOPROTEIN B-mRNA
|
US20040185101A1
(en)
*
|
2001-03-27 |
2004-09-23 |
Macromed, Incorporated. |
Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
|
US6590059B2
(en)
|
2001-05-11 |
2003-07-08 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters from dioxolane-based diketene acetals
|
WO2003000282A1
(en)
|
2001-06-21 |
2003-01-03 |
Genentech, Inc. |
Sustained release formulation
|
CA2451187C
(en)
|
2001-06-22 |
2012-08-14 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
US7345144B2
(en)
*
|
2001-07-11 |
2008-03-18 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment of cachexia
|
US7342089B2
(en)
*
|
2001-07-11 |
2008-03-11 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment for cachexia
|
US7456184B2
(en)
*
|
2003-05-01 |
2008-11-25 |
Palatin Technologies Inc. |
Melanocortin receptor-specific compounds
|
WO2003013571A1
(en)
*
|
2001-08-10 |
2003-02-20 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
US7732451B2
(en)
*
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US7655658B2
(en)
*
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
GB2404865B
(en)
*
|
2001-09-11 |
2005-09-28 |
Caretek Medical Ltd |
Novel drug delivery technology
|
GB0122318D0
(en)
*
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
ITMI20012060A1
(it)
*
|
2001-10-05 |
2003-04-05 |
Recordati Chem Pharm |
Nuovi eterocilcli n-acilati
|
EP1446100B1
(de)
*
|
2001-11-14 |
2011-05-04 |
Durect Corporation |
Injizierbare depotzusammensetzungen und deren verwendung
|
WO2003041685A1
(en)
*
|
2001-11-14 |
2003-05-22 |
Alza Corporation |
Injectable depot composition
|
NZ533436A
(en)
*
|
2001-11-14 |
2007-10-26 |
Alza Corp |
Catheter injectable depot compositons and uses thereof
|
EP1448166A1
(de)
*
|
2001-11-30 |
2004-08-25 |
Pfizer Inc. |
Polymere zusammensetzungen mit kontrollierter wirkstoffabgabe enthaltend knochenwachstumfördernde verbindungen
|
EP1484054B1
(de)
*
|
2002-02-22 |
2012-08-29 |
Santen Pharmaceutical Co., Ltd. |
Arzneimittelabgabesystem zur subkonjunktivalen verabreichung von feinen körnern
|
ES2207387B1
(es)
*
|
2002-02-28 |
2005-07-16 |
Consejo Sup. Investig. Cientificas |
Composicion quimica de igf-i para el tratamiento y prevencion de enfermedades neurodegenerativas.
|
US6960346B2
(en)
*
|
2002-05-09 |
2005-11-01 |
University Of Tennessee Research Foundation |
Vehicles for delivery of biologically active substances
|
US7432245B2
(en)
|
2002-06-07 |
2008-10-07 |
Abbott Laboratories Inc. |
Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
TWI353854B
(en)
|
2002-06-25 |
2011-12-11 |
Alza Corp |
Short duration depot formulations
|
US7160551B2
(en)
*
|
2002-07-09 |
2007-01-09 |
The Board Of Trustees Of The University Of Illinois |
Injectable system for controlled drug delivery
|
US7297348B2
(en)
*
|
2002-07-19 |
2007-11-20 |
Omeros Corporation |
Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from
|
DK1539101T3
(da)
|
2002-07-31 |
2009-04-27 |
Alza Corp |
Injicerbare, multi-modale polymere depotsammens tninger og anvendelser deraf
|
KR20050038008A
(ko)
*
|
2002-07-31 |
2005-04-25 |
알자 코포레이션 |
주사용 저장형 조성물 및 이의 용도
|
EP1575992A4
(de)
|
2002-08-05 |
2007-02-21 |
Univ Rochester |
Chimäre proteine aus proteintransduzierender domäne/deaminase, verwandte verbindungen und deren verwendungen
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
WO2004037224A1
(en)
*
|
2002-10-25 |
2004-05-06 |
Pfizer Products Inc. |
Depot formulations of arylheterocyclic active agents in the form of a suspension
|
RU2329823C2
(ru)
*
|
2002-10-29 |
2008-07-27 |
Алза Корпорейшн |
Стабилизированные твердые полипептидные частицы
|
US6918561B2
(en)
*
|
2002-10-31 |
2005-07-19 |
Yon So Chong |
Shell assembly for winding tire cord strip or belt cord strip
|
AU2003295409B2
(en)
*
|
2002-11-06 |
2010-02-11 |
Durect Corporation |
Controlled release depot formulations
|
CN100453066C
(zh)
*
|
2002-12-04 |
2009-01-21 |
参天制药株式会社 |
利用结膜下储存库的药物释放系统
|
JP2004196787A
(ja)
*
|
2002-12-04 |
2004-07-15 |
Santen Pharmaceut Co Ltd |
結膜下デポによるドラッグデリバリーシステム
|
SI1575569T1
(sl)
|
2002-12-13 |
2010-12-31 |
Durect Corp |
Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
|
BR0317421A
(pt)
*
|
2002-12-19 |
2005-11-08 |
Alza Corp |
Géis de fase única não-aquosa estável e formulações destes para liberação a partir de um dispositivo implantável
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
DK2526996T3
(da)
|
2002-12-20 |
2019-12-02 |
Xeris Pharmaceuticals Inc |
Formulering til intrakutan injektion
|
EP1442753B1
(de)
*
|
2003-02-03 |
2007-02-21 |
Polaschegg, Hans-Dietrich, Dr.techn. |
Zusammensetzung zur Prävention von Infektionen durch subkutane Prothesen
|
US6878374B2
(en)
|
2003-02-25 |
2005-04-12 |
Nitto Denko Corporation |
Biodegradable polyacetals
|
JP2007525429A
(ja)
*
|
2003-03-11 |
2007-09-06 |
キューエルティー ユーエスエー,インコーポレイテッド. |
細胞スケジュール依存性抗癌剤のための処方
|
DE10314082A1
(de)
*
|
2003-03-28 |
2004-10-21 |
Mcs Micro Carrier Systems Gmbh |
Biodegradierbares injizierbares Implantat
|
CN100548411C
(zh)
|
2003-03-31 |
2009-10-14 |
精达制药公司 |
设置有内部压力释放部件的渗透泵
|
WO2004089335A2
(en)
*
|
2003-03-31 |
2004-10-21 |
Alza Corporation |
Non-aqueous single phase vehicles and formulations utilizing such vehicles
|
JP2006521898A
(ja)
*
|
2003-03-31 |
2006-09-28 |
アルザ・コーポレーション |
浸透送り出しシステム及び浸透送り出しシステムの始動時間を短縮する方法
|
TW584939B
(en)
*
|
2003-04-23 |
2004-04-21 |
Nanya Technology Corp |
Method of forming bottle-shaped trench and the method for fabricating bottle-shaped trench capacitors
|
US7727991B2
(en)
|
2003-05-01 |
2010-06-01 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific single acyl piperazine compounds
|
US7968548B2
(en)
|
2003-05-01 |
2011-06-28 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific piperazine compounds with diamine groups
|
US7727990B2
(en)
|
2003-05-01 |
2010-06-01 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific piperazine and keto-piperazine compounds
|
AR044437A1
(es)
*
|
2003-05-29 |
2005-09-14 |
Schering Plough Ltd |
Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino
|
US20070184084A1
(en)
*
|
2003-05-30 |
2007-08-09 |
Guohua Chen |
Implantable elastomeric caprolactone depot compositions and uses thereof
|
CN1822816A
(zh)
*
|
2003-05-30 |
2006-08-23 |
阿尔萨公司 |
可植入的弹性体储库组合物、其用途以及制备方法
|
DE602004016995D1
(de)
|
2003-06-26 |
2008-11-20 |
Control Delivery Sys Inc |
In-situ gelierendes arzneimittelabgabesystem
|
CA2530113C
(en)
*
|
2003-06-26 |
2013-08-13 |
Control Delivery Systems, Inc. |
Bioerodible sustained release drug delivery systems
|
WO2005018608A1
(ja)
*
|
2003-08-20 |
2005-03-03 |
Santen Pharmaceutical Co., Ltd. |
微粒子テノン嚢下投与ドラッグデリバリーシステム
|
US7048925B2
(en)
|
2003-08-28 |
2006-05-23 |
Nitto Denko Corporation |
Acid-sensitive polyacetals and methods
|
US20050112555A1
(en)
*
|
2003-09-03 |
2005-05-26 |
Smith Harold C. |
Cytidine deaminase activators, deoxycytidine deaminase activators, Vif antagonists, and methods of screening for molecules thereof
|
EP1667732B1
(de)
|
2003-09-29 |
2010-04-21 |
Nitto Denko Corporation |
Biologisch abbaubare polyacetale für die in-vivo-abgabe von polynucleotiden
|
WO2005044254A1
(en)
*
|
2003-10-29 |
2005-05-19 |
Idexx Laboratories, Inc. |
Salts of pharmacologically active compounds
|
US20050281879A1
(en)
*
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
CN1889929B
(zh)
*
|
2003-11-14 |
2013-04-10 |
阿尔萨公司 |
药物递送媒介物中的赋形剂
|
US20050118206A1
(en)
*
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
US20050106214A1
(en)
*
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
US8329203B2
(en)
*
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
WO2005070332A1
(en)
*
|
2004-01-12 |
2005-08-04 |
The Trustees Of The University Of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
US7670771B2
(en)
|
2004-01-21 |
2010-03-02 |
University Of Utah Research Foundation |
Mutant sodium channel Nav1.7 nucleic acid methods
|
US7429391B2
(en)
*
|
2004-01-30 |
2008-09-30 |
Access Business Group International Llc |
Holistic composition and method for reducing skin pigmentation
|
US8052669B2
(en)
|
2004-02-25 |
2011-11-08 |
Femasys Inc. |
Methods and devices for delivery of compositions to conduits
|
US8048086B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
US9238127B2
(en)
|
2004-02-25 |
2016-01-19 |
Femasys Inc. |
Methods and devices for delivering to conduit
|
US8048101B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
US7709484B1
(en)
|
2004-04-19 |
2010-05-04 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
WO2005113815A2
(en)
*
|
2004-04-26 |
2005-12-01 |
Uab Research Foundation |
Polymorphisms in the fcgr2b promoter and uses thereof
|
WO2005115410A2
(en)
*
|
2004-05-06 |
2005-12-08 |
University Of Rochester |
Context dependent inhibitors of cytidine deaminases and uses thereof
|
JP2007538048A
(ja)
*
|
2004-05-17 |
2007-12-27 |
アレス トレーディング ソシエテ アノニム |
ヒドロゲル・インターフェロン製剤
|
US20050266087A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
JP4988562B2
(ja)
*
|
2004-06-01 |
2012-08-01 |
アレス トレーディング ソシエテ アノニム |
安定化したインターフェロン液体製剤
|
US7854943B2
(en)
*
|
2004-06-24 |
2010-12-21 |
Idexx Laboratories |
Phospholipid gel compositions for drug delivery and methods of treating conditions using same
|
US7858115B2
(en)
*
|
2004-06-24 |
2010-12-28 |
Idexx Laboratories |
Phospholipid gel compositions for drug delivery and methods of treating conditions using same
|
GB0417401D0
(en)
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
EP2415484B1
(de)
|
2004-09-17 |
2014-06-18 |
Durect Corporation |
Anhaltende Lokalanästhetikumzusammensetzung mit SAIB
|
ES2536460T3
(es)
*
|
2004-09-21 |
2015-05-25 |
Shandong Luye Pharmaceutical Co., Ltd. |
Formulación de acción prolongada y liberación controlada que contiene un agonista de receptores de dopamina y método de preparación de la misma
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
US8541413B2
(en)
*
|
2004-10-01 |
2013-09-24 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
EP2452670A1
(de)
*
|
2004-10-01 |
2012-05-16 |
Ramscor, Inc. |
Einfach implantierbare Arzneimittelzusammensetzungen mit verzögerter Freisetzung
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
TWI369218B
(en)
*
|
2004-12-14 |
2012-08-01 |
Novartis Ag |
In situ forming implant for animals
|
GB0428151D0
(en)
|
2004-12-22 |
2005-01-26 |
Novartis Ag |
Organic compounds
|
US20060141040A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
CN100425233C
(zh)
*
|
2005-01-12 |
2008-10-15 |
复旦大学 |
一种鼻腔用尼莫地平凝胶剂
|
US20060185678A1
(en)
*
|
2005-02-03 |
2006-08-24 |
Bronnenkant Lance J |
Devices for delivering agents to a vaginal tract
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006083761A2
(en)
*
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
JP2008528698A
(ja)
*
|
2005-02-03 |
2008-07-31 |
インターシア セラピューティクス,インコーポレイティド |
埋め込み可能なインターフェロン含有デバイス
|
US20060216242A1
(en)
*
|
2005-02-03 |
2006-09-28 |
Rohloff Catherine M |
Suspending vehicles and pharmaceutical suspensions for drug dosage forms
|
US7959938B2
(en)
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
US7674452B2
(en)
|
2005-03-16 |
2010-03-09 |
Nitto Denko Corporation |
Polymer coating of cells
|
US20060253068A1
(en)
*
|
2005-04-20 |
2006-11-09 |
Van Bilsen Paul |
Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
|
US20070015689A1
(en)
*
|
2005-06-23 |
2007-01-18 |
Alza Corporation |
Complexation of metal ions with polypeptides
|
EP1741440A1
(de)
*
|
2005-07-08 |
2007-01-10 |
Mellitus S.L. |
Verwendung von BPI-proteine zur Behandlung von stoffwechselbedingten Erkrankungen und Herzkreislaufstörungen
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
US20080247987A1
(en)
*
|
2005-08-04 |
2008-10-09 |
Angiotech International Ag |
Block Copolymer Compositions and Uses Thereof
|
US20070048288A1
(en)
*
|
2005-08-30 |
2007-03-01 |
Lyu Suping |
Shear thinning polymer cell delivery compositions
|
EP1926780B1
(de)
|
2005-09-22 |
2013-08-14 |
Medivas, LLC |
Bis-( -amino)-diol-diester-haltige poly(esteramid) und poly(esterurethan)-zusammensetzungen und verwendungsverfahren
|
WO2007038246A2
(en)
*
|
2005-09-22 |
2007-04-05 |
Medivas, Llc |
Solid polymer delivery compositions and methods for use thereof
|
US8852638B2
(en)
*
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
WO2007058190A1
(ja)
*
|
2005-11-16 |
2007-05-24 |
Tokai University Educational System |
薬剤放出制御組成物および薬剤放出性医療器具
|
WO2007067744A2
(en)
*
|
2005-12-07 |
2007-06-14 |
Medivas, Llc |
Method for assembling a polymer-biologic delivery composition
|
US20070142287A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Biomed Solutions, Llc |
Compositions And Methods For Treatment Of Cancer
|
US20070184087A1
(en)
|
2006-02-06 |
2007-08-09 |
Bioform Medical, Inc. |
Polysaccharide compositions for use in tissue augmentation
|
AU2007233123A1
(en)
*
|
2006-03-30 |
2007-10-11 |
Palatin Technologies, Inc. |
Linear natriuretic peptide constructs
|
DK2001518T3
(da)
*
|
2006-03-30 |
2013-10-07 |
Palatin Technologies Inc |
Cykliske natriuretiske peptidfremstillinger
|
US8580746B2
(en)
*
|
2006-03-30 |
2013-11-12 |
Palatin Technologies, Inc. |
Amide linkage cyclic natriuretic peptide constructs
|
CA2649672C
(en)
*
|
2006-05-02 |
2015-07-07 |
Medivas, Llc |
Delivery of ophthalmologic agents to the exterior or interior of the eye
|
US20070282011A1
(en)
*
|
2006-05-09 |
2007-12-06 |
Medivas, Llc |
Biodegradable water soluble polymers
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
GB0613333D0
(en)
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
GB0613638D0
(en)
|
2006-07-08 |
2006-08-16 |
Controlled Therapeutics Sct |
Polyurethane elastomers
|
WO2008017661A1
(en)
|
2006-08-07 |
2008-02-14 |
Novozymes A/S |
Enzyme granules for animal feed
|
EP3072399B1
(de)
|
2006-08-07 |
2018-12-19 |
Novozymes A/S |
Enzymgranulat für tierfutter
|
DK2049081T3
(da)
|
2006-08-09 |
2013-02-25 |
Intarcia Therapeutics Inc |
Osmotiske leveringssystemer og stempelarrangementer
|
US20080038332A1
(en)
*
|
2006-08-10 |
2008-02-14 |
Cai Gu Huang |
Stable pharmaceutical formulation comprising atorvastatin calcium
|
US7834017B2
(en)
|
2006-08-11 |
2010-11-16 |
Palatin Technologies, Inc. |
Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
|
GB0620685D0
(en)
|
2006-10-18 |
2006-11-29 |
Controlled Therapeutics Sct |
Bioresorbable polymers
|
US8999317B2
(en)
|
2006-11-01 |
2015-04-07 |
University Of Rochester |
Methods and compositions related to the structure and function of APOBEC3G
|
DK2117521T3
(da)
|
2006-11-03 |
2012-09-03 |
Durect Corp |
Transdermale indgivelsessystemer omfattende bupivacain
|
US7718616B2
(en)
|
2006-12-21 |
2010-05-18 |
Zimmer Orthobiologics, Inc. |
Bone growth particles and osteoinductive composition thereof
|
KR100825519B1
(ko)
*
|
2007-01-05 |
2008-04-25 |
주식회사 바이오폴리메드 |
키토산 기재 고분자 접합체 및 그 제조방법
|
ES2402172T3
(es)
|
2007-04-23 |
2013-04-29 |
Intarcia Therapeutics, Inc |
Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
|
EP2167039B1
(de)
*
|
2007-05-18 |
2016-09-28 |
Durect Corporation |
Verbesserte depot-formulierungen
|
CA2687979C
(en)
|
2007-05-25 |
2017-07-04 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of risperidone compounds
|
US10092524B2
(en)
*
|
2008-06-11 |
2018-10-09 |
Edge Therapeutics, Inc. |
Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
|
EP2178944A1
(de)
*
|
2007-07-24 |
2010-04-28 |
Medivas, LLC |
Biologisch abbaubare polymere genübertragungszusammensetzungen und anwendungsverfahren dafür
|
US8470360B2
(en)
*
|
2008-04-18 |
2013-06-25 |
Warsaw Orthopedic, Inc. |
Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
|
BRPI0819175A2
(pt)
*
|
2007-11-05 |
2015-05-05 |
Bausch & Lomb |
Composição farmacêutica oftálmica, e, método para proporcionar disponibilidade estendida de um componente farmacêutico em um ambiente ocular de um indivíduo, e, uso de pelo menos um componente farmacêutico, pelo menos um material imiscível em água e opcionalmente um composto modificador de viscosidade
|
WO2009060473A2
(en)
*
|
2007-11-06 |
2009-05-14 |
Panacea Biotec Limited |
Injectable compositions, processes and uses thereof
|
US9090737B2
(en)
|
2007-11-13 |
2015-07-28 |
Surmodics, Inc. |
Viscous terpolymers as drug delivery platform
|
CA2706931C
(en)
|
2007-12-06 |
2015-05-12 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
BRPI0821029A2
(pt)
*
|
2007-12-20 |
2015-06-16 |
Merck Serono Sa |
Fomulações de peg-interferon-beta
|
US20090181068A1
(en)
*
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
CN101951903A
(zh)
*
|
2008-02-15 |
2011-01-19 |
骨治疗公司 |
用于治疗或预防骨关节疾病的药物组合物
|
JP2011512345A
(ja)
|
2008-02-15 |
2011-04-21 |
ボーン・セラピューティクス |
骨関節疾患の治療及び/または予防において使用する医薬組成物
|
US8828354B2
(en)
|
2008-03-27 |
2014-09-09 |
Warsaw Orthopedic, Inc. |
Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
US9072727B2
(en)
*
|
2008-04-18 |
2015-07-07 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of degenerative disc disease
|
US9125917B2
(en)
|
2008-04-18 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Fluocinolone formulations in a biodegradable polymer carrier
|
US20090264478A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Sulfasalazine formulations in a biodegradable polymer carrier
|
US8846068B2
(en)
*
|
2008-04-18 |
2014-09-30 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising a local anesthetic
|
US9132085B2
(en)
|
2008-04-18 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating post-operative pain using clonidine and bupivacaine
|
US20090264477A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc., An Indiana Corporation |
Beta adrenergic receptor agonists for treatment of pain and/or inflammation
|
US8956641B2
(en)
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of inflammatory diseases
|
US8557273B2
(en)
*
|
2008-04-18 |
2013-10-15 |
Medtronic, Inc. |
Medical devices and methods including polymers having biologically active agents therein
|
US8420114B2
(en)
|
2008-04-18 |
2013-04-16 |
Warsaw Orthopedic, Inc. |
Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
|
US8956636B2
(en)
|
2008-04-18 |
2015-02-17 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating postoperative pain comprosing ketorolac
|
US20090264489A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedic, Inc. |
Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
|
US9132119B2
(en)
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
US8524267B2
(en)
*
|
2008-04-18 |
2013-09-03 |
Warsaw Orthopedic, Inc. |
Dexamethasone formulations in a biodegradable material
|
USRE48948E1
(en)
|
2008-04-18 |
2022-03-01 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
US8629172B2
(en)
|
2008-04-18 |
2014-01-14 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating post-operative pain comprising clonidine
|
US9289409B2
(en)
*
|
2008-04-18 |
2016-03-22 |
Warsaw Orthopedic, Inc. |
Sulindac formulations in a biodegradable material
|
US20090263443A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Warsaw Orthopedics, Inc. |
Methods for treating post-operative effects such as spasticity and shivering with clondine
|
US8722079B2
(en)
*
|
2008-04-18 |
2014-05-13 |
Warsaw Orthopedic, Inc. |
Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
|
US8889173B2
(en)
*
|
2008-04-18 |
2014-11-18 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
|
US20100015049A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents
|
US20100016808A1
(en)
*
|
2008-07-17 |
2010-01-21 |
Bioform Medical, Inc. |
Thin-Walled Delivery System
|
US9492375B2
(en)
|
2008-07-23 |
2016-11-15 |
Warsaw Orthopedic, Inc. |
Foam carrier for bone grafting
|
JP2012500207A
(ja)
*
|
2008-08-13 |
2012-01-05 |
メディバス エルエルシー |
Aabb−ポリ(デプシペプチド)生分解性ポリマー及び使用方法
|
US10070888B2
(en)
|
2008-10-03 |
2018-09-11 |
Femasys, Inc. |
Methods and devices for sonographic imaging
|
US9554826B2
(en)
|
2008-10-03 |
2017-01-31 |
Femasys, Inc. |
Contrast agent injection system for sonographic imaging
|
NZ592113A
(en)
*
|
2008-10-15 |
2012-04-27 |
Intarcia Therapeutics Inc |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
US20100098746A1
(en)
*
|
2008-10-20 |
2010-04-22 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
|
US9161903B2
(en)
|
2008-10-31 |
2015-10-20 |
Warsaw Orthopedic, Inc. |
Flowable composition that hardens on delivery to a target tissue site beneath the skin
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
EP2362866B1
(de)
|
2008-11-11 |
2015-07-08 |
Signum Biosciences, Inc. |
Isoprenyl mittel und sein verfahren
|
WO2010065799A2
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Amine substituted piperidine melanocortin receptor-specific compounds
|
WO2010065801A1
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Amine substituted piperazine melanocortin receptor-specific compounds
|
WO2010065802A2
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Substituted pyrrolidine or imidazolidine melanocortin receptor-specific compounds
|
US8951546B2
(en)
*
|
2008-12-23 |
2015-02-10 |
Surmodics Pharmaceuticals, Inc. |
Flexible implantable composites and implants comprising same
|
US8980317B2
(en)
|
2008-12-23 |
2015-03-17 |
Warsaw Orthopedic, Inc. |
Methods and compositions for treating infections comprising a local anesthetic
|
US8974808B2
(en)
*
|
2008-12-23 |
2015-03-10 |
Surmodics, Inc. |
Elastic implantable composites and implants comprising same
|
US20100168807A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Burton Kevin W |
Bioactive terpolymer compositions and methods of making and using same
|
US9480643B2
(en)
|
2008-12-23 |
2016-11-01 |
Surmodics Pharmaceuticals, Inc. |
Implantable composites and implants comprising same
|
US9415197B2
(en)
*
|
2008-12-23 |
2016-08-16 |
Surmodics, Inc. |
Implantable suction cup composites and implants comprising same
|
US20100228097A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Methods and compositions to diagnose pain
|
US20100226959A1
(en)
*
|
2009-03-04 |
2010-09-09 |
Warsaw Orthopedic, Inc. |
Matrix that prolongs growth factor release
|
US20100239632A1
(en)
|
2009-03-23 |
2010-09-23 |
Warsaw Orthopedic, Inc. |
Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
|
EA020959B1
(ru)
|
2009-06-08 |
2015-03-31 |
Палатин Текнолоджиз, Инк. |
Пептиды, специфичные к меланокортиновым рецепторам
|
US8617583B2
(en)
|
2009-07-17 |
2013-12-31 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
|
US8653029B2
(en)
|
2009-07-30 |
2014-02-18 |
Warsaw Orthopedic, Inc. |
Flowable paste and putty bone void filler
|
US8231891B2
(en)
|
2009-07-31 |
2012-07-31 |
Warsaw Orthopedic, Inc. |
Implantable drug depot for weight control
|
EP2464389A2
(de)
|
2009-08-06 |
2012-06-20 |
Koninklijke Philips Electronics N.V. |
Tumortherapien mit radioaktiven seeds
|
CN107638562B
(zh)
*
|
2009-09-28 |
2022-12-02 |
精达制药公司 |
基本稳态药物递送的快速建立和/或终止
|
US20110097375A1
(en)
|
2009-10-26 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Formulation for preventing or reducing bleeding at a surgical site
|
US20110097380A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Clonidine formulations having antimicrobial properties
|
US9504698B2
(en)
*
|
2009-10-29 |
2016-11-29 |
Warsaw Orthopedic, Inc. |
Flowable composition that sets to a substantially non-flowable state
|
US8597192B2
(en)
|
2009-10-30 |
2013-12-03 |
Warsaw Orthopedic, Inc. |
Ultrasonic devices and methods to diagnose pain generators
|
ES2591108T3
(es)
|
2009-11-12 |
2016-11-24 |
Signum Biosciences Inc. |
Uso de agentes antibacterianos para el tratamiento de afecciones de tipo epitelial
|
US9993441B2
(en)
|
2009-12-30 |
2018-06-12 |
Surmodics, Inc. |
Controlled release matrix barrier structure for subcutaneous medical devices
|
US8475824B2
(en)
*
|
2010-01-26 |
2013-07-02 |
Warsaw Orthopedic, Inc. |
Resorbable matrix having elongated particles
|
US8758791B2
(en)
*
|
2010-01-26 |
2014-06-24 |
Warsaw Orthopedic, Inc. |
Highly compression resistant matrix with porous skeleton
|
US9050274B2
(en)
*
|
2010-01-28 |
2015-06-09 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents
|
US9486500B2
(en)
|
2010-01-28 |
2016-11-08 |
Warsaw Orthopedic, Inc. |
Osteoimplant and methods for making
|
US9125902B2
(en)
*
|
2010-01-28 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Methods for treating an intervertebral disc using local analgesics
|
JP2013522239A
(ja)
*
|
2010-03-12 |
2013-06-13 |
サーモディクス,インコーポレイテッド |
注射用薬物送達システム
|
JP5866332B2
(ja)
*
|
2010-03-17 |
2016-02-17 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
感光性イオンを通過させる分子
|
US10335366B2
(en)
|
2010-05-31 |
2019-07-02 |
Laboratorios Farmacéuticos Rovi, S.A. |
Risperidone or paliperidone implant formulation
|
US10285936B2
(en)
|
2010-05-31 |
2019-05-14 |
Laboratorios Farmacéuticos Rovi, S.A. |
Injectable composition with aromatase inhibitor
|
US10350159B2
(en)
|
2010-05-31 |
2019-07-16 |
Laboratories Farmacéuticos Rovi, S.A. |
Paliperidone implant formulation
|
ES2589106T3
(es)
|
2010-05-31 |
2016-11-10 |
Laboratorios Farmaceuticos Rovi, S.A. |
Composición inyectable antipsicótica de liberación controlada
|
US10463607B2
(en)
|
2010-05-31 |
2019-11-05 |
Laboratorios Farmaceutics Rofi S.A. |
Antipsychotic Injectable Depot Composition
|
US10881605B2
(en)
|
2010-05-31 |
2021-01-05 |
Laboratorios Farmaceuticos Rovi, S.A. |
Methods for the preparation of injectable depot compositions
|
LT2394663T
(lt)
|
2010-05-31 |
2022-02-10 |
Laboratorios Farmaceuticos Rovi, S.A. |
Kompozicijos, skirtos įšvirkščiamiems in situ biologiškai skaidiems implantams
|
WO2011161531A1
(en)
*
|
2010-06-24 |
2011-12-29 |
Torrent Pharmaceuticals Limited |
Pharmaceutical composition containing goserelin for in-situ implant
|
WO2012012460A1
(en)
|
2010-07-19 |
2012-01-26 |
Xeris Pharmaceuticals, Inc. |
Stable glucagon formulations for the treatment of hypoglycemia
|
US8246571B2
(en)
|
2010-08-24 |
2012-08-21 |
Warsaw Orthopedic, Inc. |
Drug storage and delivery device having a retaining member
|
WO2012030819A1
(en)
|
2010-08-30 |
2012-03-08 |
Surmodics Pharmaceuticals, Inc. |
Terpolymers as pressure-sensitive adhesives
|
US10525169B2
(en)
|
2010-10-20 |
2020-01-07 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US11291483B2
(en)
|
2010-10-20 |
2022-04-05 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants
|
US10525168B2
(en)
|
2010-10-20 |
2020-01-07 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US11484627B2
(en)
|
2010-10-20 |
2022-11-01 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US20120101593A1
(en)
|
2010-10-20 |
2012-04-26 |
BIOS2 Medical, Inc. |
Implantable polymer for bone and vascular lesions
|
US11058796B2
(en)
|
2010-10-20 |
2021-07-13 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US11207109B2
(en)
|
2010-10-20 |
2021-12-28 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US8740982B2
(en)
|
2010-10-26 |
2014-06-03 |
Kyphon Sarl |
Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis
|
US9414930B2
(en)
|
2010-10-26 |
2016-08-16 |
Kyphon SÀRL |
Activatable devices containing a chemonucleolysis agent
|
US8404268B2
(en)
|
2010-10-26 |
2013-03-26 |
Kyphon Sarl |
Locally targeted anti-fibrotic agents and methods of use
|
JP2013542837A
(ja)
|
2010-11-15 |
2013-11-28 |
ジンマー オーソバイオロジクス,インコーポレイティド |
骨空隙充填剤
|
US8623396B2
(en)
|
2010-12-03 |
2014-01-07 |
Warsaw Orthopedic, Inc. |
Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
|
US9301946B2
(en)
|
2010-12-03 |
2016-04-05 |
Warsaw Orthopedic, Inc. |
Clonidine and GABA compounds in a biodegradable polymer carrier
|
US9060978B2
(en)
|
2011-01-24 |
2015-06-23 |
Warsaw Orthopedic, Inc. |
Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist
|
US9717779B2
(en)
|
2011-01-31 |
2017-08-01 |
Warsaw Orthopedic, Inc. |
Implantable matrix having optimum ligand concentrations
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
CN103442695B
(zh)
|
2011-03-10 |
2016-05-04 |
Xeris药物公司 |
肠胃外注射用肽药物的稳定制剂
|
GB2513675A
(en)
*
|
2011-04-05 |
2014-11-05 |
Edge Therapeutics |
Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
|
US9511077B2
(en)
|
2011-04-25 |
2016-12-06 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an anabolic agent for wound healing
|
US9592243B2
(en)
|
2011-04-25 |
2017-03-14 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an anabolic agent for treatment of an injury
|
EP3159368A1
(de)
|
2011-06-23 |
2017-04-26 |
DSM IP Assets B.V. |
Neue biologisch abbaubare polyesteramid-copolymere zur arzneimittelabgabe
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
US9132194B2
(en)
|
2011-07-12 |
2015-09-15 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an adhesive sheet containing a drug depot
|
US9205241B2
(en)
|
2011-07-12 |
2015-12-08 |
Warsaw Orthopedic, Inc. |
Medical devices and methods comprising an adhesive material
|
CA2853942C
(en)
|
2011-10-31 |
2020-08-25 |
Xeris Pharmaceuticals, Inc. |
Formulations for the treatment of diabetes
|
EP2806853B1
(de)
*
|
2012-01-23 |
2020-07-08 |
Allergan, Inc. |
Zeitlich freigegebene, biologisch abbaubare oder biologisch erodierbare mikrokugeln oder mikropartikel in einer sich verfestigenden, depotbildenden, injizierbaren arzneimittelformulierung
|
WO2013130877A1
(en)
|
2012-02-29 |
2013-09-06 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, including the use of composite implants
|
US9534018B2
(en)
|
2012-03-13 |
2017-01-03 |
Tensive Controls Inc. |
Melanocortin analogs having enhanced activity and transport
|
US9511018B2
(en)
|
2012-04-05 |
2016-12-06 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable matrix
|
US8735504B2
(en)
|
2012-05-02 |
2014-05-27 |
Warsaw Orthopedic, Inc. |
Methods for preparing polymers having low residual monomer content
|
US9125805B2
(en)
|
2012-06-27 |
2015-09-08 |
Xeris Pharmaceuticals, Inc. |
Stable formulations for parenteral injection of small molecule drugs
|
US8835601B2
(en)
*
|
2012-12-21 |
2014-09-16 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptide delivery systems
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
US9018162B2
(en)
|
2013-02-06 |
2015-04-28 |
Xeris Pharmaceuticals, Inc. |
Methods for rapidly treating severe hypoglycemia
|
US9737605B2
(en)
|
2013-03-11 |
2017-08-22 |
Durect Corporation |
Injectable controlled release composition comprising high viscosity liquid carrier
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
AU2014228313B2
(en)
|
2013-03-15 |
2019-01-17 |
Heron Therapeutics, Inc. |
Compositions of a polyorthoester and an aprotic solvent
|
EP2983468A4
(de)
|
2013-03-15 |
2016-09-07 |
Durect Corp |
Zusammensetzungen mit rheologiemodifikator zur reduzierung der auflösungsvariabilität
|
JP2016525379A
(ja)
|
2013-05-23 |
2016-08-25 |
206 オーソ,インコーポレーテッド |
複合材インプラントの提供および使用を含む、骨折を治療するための、ならびに/または、骨を補強および/もしくは増強するための方法および装置
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
US9764122B2
(en)
|
2014-07-25 |
2017-09-19 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having an occluding member
|
AU2015300944B2
(en)
|
2014-08-06 |
2019-07-11 |
Xeris Pharmaceuticals, Inc. |
Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
|
WO2016044683A1
(en)
|
2014-09-19 |
2016-03-24 |
Tensive Controls, Inc. |
Anti-microbial peptides
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
CN107106509B
(zh)
|
2014-12-18 |
2021-11-30 |
帝斯曼知识产权资产管理有限公司 |
用于递送酸敏感药物的药物递送系统
|
JP6956009B2
(ja)
*
|
2014-12-29 |
2021-10-27 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
化学療法剤の多段階放出のための組成物、装置、および方法
|
WO2016168388A2
(en)
|
2015-04-14 |
2016-10-20 |
Palatin Technologies, Inc. |
Therapies for obesity, diabetes and related indications
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
US9649364B2
(en)
|
2015-09-25 |
2017-05-16 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic formulations in aprotic polar solvents
|
US11590205B2
(en)
|
2015-09-25 |
2023-02-28 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
BR112018073511A2
(pt)
|
2016-05-16 |
2019-03-26 |
Intarcia Therapeutics, Inc. |
polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD802756S1
(en)
|
2016-06-23 |
2017-11-14 |
Warsaw Orthopedic, Inc. |
Drug pellet cartridge
|
EP3487975A1
(de)
|
2016-07-19 |
2019-05-29 |
Ecolab USA Inc. |
Verfahren und reinigungslösungen zur entfernung von kaugummi und anderen klebrigen lebensmittelsubstanzen
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
MX2019008006A
(es)
|
2017-01-03 |
2019-08-29 |
Intarcia Therapeutics Inc |
Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
|
CN117085022A
(zh)
|
2017-06-02 |
2023-11-21 |
Xeris药物公司 |
抗沉淀的小分子药物制剂
|
CN107595765A
(zh)
*
|
2017-09-22 |
2018-01-19 |
沈阳兴齐眼药股份有限公司 |
一种眼用缓释药物递送系统及其制备方法
|
US20210121428A1
(en)
*
|
2019-10-25 |
2021-04-29 |
Warsaw Orthopedic, Inc. |
Compositions for treatment of annular spinal disc injury
|
CA3167217A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
CN112516372A
(zh)
*
|
2020-11-12 |
2021-03-19 |
盐城工学院 |
一种用于可吸收手术缝合线的复合载药纤维
|
AU2022343289A1
(en)
|
2021-09-09 |
2024-02-29 |
Xeris Pharmaceuticals, Inc. |
Injectable high concentration pharmaceutical formulations and methods of manufacturing and use thereof
|
TW202313047A
(zh)
|
2021-09-21 |
2023-04-01 |
西班牙商禾霏藥品實驗室有限公司 |
抗精神病可注射儲積型組合物
|